An archive of stories from the research ethics community


Richard Klein discusses his sense of the "inter-relatedness" of the various aspects of research ethics and the work of the FDA to monitor drug development and encourage patient participation in the design and evaluation of clinical studies. (December, 2014)

3:47 The Savannah River Ecology Laboratory
8:48 The Common Rule and flexibility (Watch Excerpt)
15:53 HIV/AIDS and the FDA (Watch Excerpt)
21:19 HIV/AIDS activists (Watch Excerpt)
25:55 Expanded access (Watch Excerpt)
29:31 Lessons from the HIV/AIDS activists (Watch Excerpt)
31:57 The Patient Representative Program (Watch Excerpt)
40:04 The reintroduction of thalidomide (Watch Excerpt)
48:43 Challenges for the FDA today
49:56 Access to study drugs